-
Je něco špatně v tomto záznamu ?
Long-Term Efficacy and Safety of Enzalutamide Monotherapy in Elderly Patients with Metastatic Castration-Resistant Prostate Cancer: A Case Report
T. Pokrivcak, J. Navratil, A. Poprach, M. Stanik, I. Kiss
Status neindexováno Jazyk angličtina Země Švýcarsko
Typ dokumentu kazuistiky
NLK
Directory of Open Access Journals
od 2008
Free Medical Journals
od 2008
PubMed Central
od 2008
Europe PubMed Central
od 2008
ProQuest Central
od 2017-01-01
Open Access Digital Library
od 2008-01-01
Open Access Digital Library
od 2008-01-01
Health & Medicine (ProQuest)
od 2017-01-01
Karger Open Access
od 2008-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2008
PubMed
38577248
DOI
10.1159/000538124
Knihovny.cz E-zdroje
- Publikační typ
- kazuistiky MeSH
INTRODUCTION: Prostate cancer is one of the most common cancers in men. Despite the sharp rise in incidence, mortality is decreasing. ARTA preparations are preferred options for asymptomatic or mildly symptomatic patients with mCRPC. The use of enzalutamide in elderly patients with mCRPC is risky and depends on a number of factors. An increased risk of falls and fractures has been shown. CASE PRESENTATION: We present a case report of an elderly patient with mCRPC treated with enzalutamide with very good long-term tolerance and efficacy. CONCLUSION: Despite the older age, no reduction of therapy was necessary in the patient due to good tolerance. Administration of enzalutamide in full doses resulted in a very good effect of therapy.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24013063
- 003
- CZ-PrNML
- 005
- 20240903092416.0
- 007
- ta
- 008
- 240723s2024 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1159/000538124 $2 doi
- 035 __
- $a (PubMed)38577248
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Pokrivcak, Tomas $u Masaryk Memorial Cancer Institute, Brno, Czech Republic $u Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 245 10
- $a Long-Term Efficacy and Safety of Enzalutamide Monotherapy in Elderly Patients with Metastatic Castration-Resistant Prostate Cancer: A Case Report / $c T. Pokrivcak, J. Navratil, A. Poprach, M. Stanik, I. Kiss
- 520 9_
- $a INTRODUCTION: Prostate cancer is one of the most common cancers in men. Despite the sharp rise in incidence, mortality is decreasing. ARTA preparations are preferred options for asymptomatic or mildly symptomatic patients with mCRPC. The use of enzalutamide in elderly patients with mCRPC is risky and depends on a number of factors. An increased risk of falls and fractures has been shown. CASE PRESENTATION: We present a case report of an elderly patient with mCRPC treated with enzalutamide with very good long-term tolerance and efficacy. CONCLUSION: Despite the older age, no reduction of therapy was necessary in the patient due to good tolerance. Administration of enzalutamide in full doses resulted in a very good effect of therapy.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a kazuistiky $7 D002363
- 700 1_
- $a Navrátil, Jiří $u Masaryk Memorial Cancer Institute, Brno, Czech Republic $u Faculty of Medicine, Masaryk University, Brno, Czech Republic $7 xx0164164
- 700 1_
- $a Poprach, Alexandr $u Masaryk Memorial Cancer Institute, Brno, Czech Republic $u Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Stanik, Michal $u Masaryk Memorial Cancer Institute, Brno, Czech Republic $u Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Kiss, Igor $u Masaryk Memorial Cancer Institute, Brno, Czech Republic $u Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 773 0_
- $w MED00173224 $t Case reports in oncology $x 1662-6575 $g Roč. 17, č. 1 (2024), s. 537-542
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38577248 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240723 $b ABA008
- 991 __
- $a 20240903092413 $b ABA008
- 999 __
- $a ok $b bmc $g 2125586 $s 1224926
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2024 $b 17 $c 1 $d 537-542 $e 20240404 $i 1662-6575 $m Case reports in oncology $n Case Rep Oncol $x MED00173224
- LZP __
- $a Pubmed-20240723